PureTech Health LLC
Records under this name other than the patents PureTech Health LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,680,123 | Substituted N-Aryl Pyridinones now held by Celea Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 8,969,575 | Substituted N-Aryl Pyridinones now held by Celea Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 8,969,576 | Substituted N-Aryl Pyridinones now held by Celea Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 9,062,001 | Substituted N-Aryl Pyridinones now held by Celea Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 9,504,677 | Substituted N-Aryl Pyridinones now held by Celea Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 8,383,823 | Substituted N-Aryl Pyridinones now held by Celea Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 11,975,029 | Compositions and Methods for Inhibition of Lineage Specific Proteins conveyed to Vor Biopharma Inc. - now held by Syzygymed Inc. In force · High confidence | In force | High confidence | |
| US 10,344,091 | ANTI-GALECTIN-9 Antibodies and Uses Thereof now held by PureTech Lyt, Inc. In force · High confidence | In force | High confidence | |
| US 10,450,374 | ANTI-GALECTIN-9 Antibodies and Uses Thereof now held by PureTech Lyt, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 11,629,191 | ANTI-GALECTIN-9 Antibodies and Uses Thereof now held by PureTech Lyt, Inc. In force · Low confidence | In force | Low confidence |